Volume 69, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Post-treatment reactions to single-dose ivermectin (200 μg/kg) and albendazole (400 mg) were studied in a filarial endemic region of Mali. The prevalence of in this region was 48.3% (69 of 143), and coinfection with was common (30 of 40, 75%). Microfilarial levels of correlated positively with age ( = 0.006) and with microfilarial levels ( = 0.006). Forty individuals (28 infected and 12 uninfected) were treated, with mild post-treatment reactions occurring in 35.7% (7 of 28) of the -infected subjects. Reaction severity correlated with pretreatment microfilarial levels ( = 0.001). There were no significant differences in the prevalence or severity of post-treatment reactions in those who were co-infected with . It is concluded that co-infection with does not significantly alter the post-treatment reaction profile to single-dose ivermectin/albendazole in infection in this community, and that acute post-treatment reactions should not limit patient compliance in community-based programs to eliminate lymphatic filariasis.


Article metrics loading...

Loading full text...

Full text loading...



  1. Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV, 2000. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. Parasitology 121 (Suppl): S147–S160.
  2. Cartel JL, Celerier P, Spiegel A, Burucoa C, Roux JF, 1990. A single diethylcarbamazine dose for treatment of Wuchereria bancrofti carriers in French Polynesia: efficacy and side effects. Southeast Asian J Trop Med Public Health 21 : 465–470.
  3. Prasad GB, Ramaprasad P, Rao VS, Bharati MS, Harinath BC, 1990. Efficacy of two different DEC regimens in the treatment of human filarial infection. Indian J Med Res 91 : 133–137.
  4. Francis H, Awadzi K, Ottesen EA, 1985. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity. Am J Trop Med Hyg 34 : 529–536.
  5. Ottesen EA, Vijayasekaran V, Kumaraswami V, Perumal Pillai SV, Sadanandam A, Frederick S, Prabhakar R, Tripathy SP, 1990. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. N Engl J Med 322 : 1113–1117.
  6. Subramanyam Reddy G, Vengatesvarlou N, Das PK, Vanamail P, Vijayan AP, Kala S, Pani SP, 2000. Tolerability and efficacy of single-dose diethylcarbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India. Trop Med Int Health 5 : 779–785.
  7. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekera N, de Silva DC, Michalski ML, Dissanaike AS, 1998. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 92 : 94–97.
  8. Addiss DG, Beach MJ, Streit TG, Lutwick S, LeConte FH, Lafontant JG, Hightower AW, Lammie PJ, 1997. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 350 : 480–484.
  9. Dunyo SK, Nkrumah FK, Simonsen PE, 2000. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg 94 : 205–211.
  10. Molyneux DH, Taylor MJ, 2001. Current status and future prospects of the Global Lymphatic Filariasis Programme. Curr Opin Infect Dis 14 : 155–159.
  11. Gardon J, Kamgno J, Gardon-Wendel N, Demanga N, Duke BO, Boussinesq M, 2002. Efficacy of repeated doses of ivermectin against Mansonella perstans. Trans R Soc Trop Med Hyg 96 : 325–326.
  12. Schulz-Key H, Albrecht W, Heuschkel C, Soboslay PT, Banla M, Gorgen H, 1993. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients. Trans R Soc Trop Med Hyg 87 : 227–229.
  13. Lipani F, Caramello P, Biglino A, Sacchi C, 1997. Albendazole for the treatment of Mansonella perstans filariasis. Trans R Soc Trop Med Hyg 91 : 221.
  14. Duong TH, Kombila M, Ferrer A, Nguiri C, Richard-Lenoble D, 1998. Decrease in Mansonella perstans microfilaraemia after albendazole treatment. Trans R Soc Trop Med Hyg 92 : 459.
  15. Maizels RM, Gomez-Escobar N, Gregory WF, Murray J, Zang X, 2001. Immune evasion genes from filarial nematodes. Int J Parasitol 31 : 889–898.
  16. Cross HF, Haarbrink M, Egerton G, Yazdanbakhsh M, Taylor MJ, 2001. Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet 358 : 1873–1875.
  17. Rajgor D, Gogtay NJ, Garg BS, Deshmukh PR, Kshirsagar NA, 2002. Reading ICT filariasis rapid diagnostic card tests under field conditions and issues of good clinical practice in clinical trials. Trans R Soc Trop Med Hyg 96 : 574–575.
  18. Zimmerman PA, Guderian RH, Aruajo E, Elson L, Phadke P, Kubofcik J, Nutman TB, 1994. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis 169 : 686–689.
  19. Richards FO Jr, Eberhard ML, Bryan RT, McNeeley DF, Lammie PJ, McNeeley MB, Bernard Y, Hightower AW, Spencer HC, 1991. Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti. Am J Trop Med Hyg 44 : 3–10.
  20. Cartel JL, Moulia-Pelat JP, Glaziou P, Nguyen LN, Chanteau S, Roux JF, 1992. Results of a safety trial on single-dose treatments with 400 mcg/kg of ivermectin in bancroftian filariasis. Trop Med Parasitol 43 : 263–266.
  21. Kar SK, Patnaik S, Kumaraswami V, Murty RS, 1993. Side reactions following ivermectin therapy in high density bancroftian microfilaraemics. Acta Trop 55 : 21–31.
  22. Coutinho AD, Dreyer G, Medeiros Z, Lopes E, Machado G, Galdino E, Rizzo JA, Andrade LD, Rocha A, Moura I, Godoy J, Ottesen EA, 1994. Ivermectin treatment of bancroftian filariasis in Recife, Brazil. Am J Trop Med Hyg 50 : 339–348.
  23. Onapa AW, Simonsen PE, Pedersen EM, Okello DO, 2001. Lymphatic filariasis in Uganda: baseline investigations in Lira, Soroti and Katakwi districts. Trans R Soc Trop Med Hyg 95 : 161–167.
  24. Ufomadu GO, Nwoke BE, Akoh JI, Sato Y, Ekejindu GO, Uchida A, Shiwaku K, Tumbau M, Ugomo KK, 1990. The occurrence of loiasis, mansonellosis and wuchereriasis in the Jarawa River Valley, central Nigeria. Acta Trop 48 : 137–147.
  25. Mommers EC, Dekker HS, Richard P, Garica A, Chippaux JP, 1995. Prevalence of L. loa and M. perstans filariasis in southern Cameroon. Trop Geogr Med 47 : 2–5.
  26. Noireau F, Pichon G, 1992. Population dynamics of Loa loa and Mansonella perstans infections in individuals living in an endemic area of the Congo. Am J Trop Med Hyg 46 : 672–676.
  27. Weil GJ, Lammie PJ, Weiss N, 1997. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitology Today 13 : 401–404.
  28. Gyapong JO, Adjei S, Sackey SO, 1996. Descriptive epidemiology of lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg 90 : 26–30.

Data & Media loading...

  • Received : 03 Apr 2003
  • Accepted : 01 Jul 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error